Objective: Assessment of the physiological effects of a diet rich in phosphorus in young women. Design: Control period I Ð commercial basic diet containing 1700 mg P and 1500 mg Caaday for 4 weeks. Supplementation period Ð a 6 week high-phosphorus period of 3008 mg P and 1995 mg Caaday. Control period II Ð 4 weeks washout with basic diet as in period I. Setting: Institute of Nutritional Science, Friedrich Schiller University, Jena. Subjects: Ten healthy women, aged 20 ± 30 y. Interventions: Orange juice and tablets, containing supplements of Ca 5 (PO 4 ) 3 OH and NaH 2 PO 4 , totalling 1436 mg elemental phosphorus per day. Results: There was an increase of 10.7 AE 13.7 pgaml in serum PTH, a decrease of 0.6AE 0.6 ngaml in serum osteocalcin, an increase of 73.6 AE 136.6 nmolammol creatinine in urinary pyridinoline and of 19.3 AE 36.0 nmola mmol creatinine in urinary deoxypyridinoline, and a decrease of 2.6 AE 9.3 mgal in urinary microalbumin. All changes were insigni®cant. There were no changes in serum levels of Ca, PO 4 or Zn, in serum concentration of 1,25-(OH) 2 D 3 , and in urinary b-2-microglobulin excretion. Phosphorus supplementation caused intestinal distress, soft stools or mild diarrhoea. Conclusions: In spite of a high phosphorus supplementation no signi®cant changes in bone-related hormones, pyridinium crosslinks as markers of bone resorption and parameters of renal function in young women were found.
Introduction
Because of the prevalence of the element phosphorus and of phosphorus compounds in many food products, their use as food additives is often discussed with respect to their possible stimulating effect on adult bone resorption and proximal tubular function (Hoshino et al, 1998; Lobaugh, 1995) . The majority of phosphorus is consumed via foods rich in protein, such as meat and dairy products. Additionally, a wide variety of processed foods, including carbonated beverages, cheese, dressings and refrigerated bakery products, are currently supplemented with phosphates. Depending on individual food selection, it appears that such additives may increase the intake of phosphorus by 0.5 ± 1.5 g per day (Feldheim and Kratzat, 1978) . The recommended daily intake of phosphorus is relative to that of calcium. The German Society of Nutrition recommends a dietary calcium intake of 1000 mg per day for adults while the phosphorus intake amounts to 700 mg per day (Deutsche Gesellschaft fu Èr Erna Èhrung, 2000).
Hypophosphatemia
The ubiquitous occurrence of phosphorus in foods coupled with the generally high bioavailability of P nearly excludes the possibility of de®ciency. In rare instances hypophosphatemia may be due to defective gastrointestinal absorption (eg vitamin D de®ciency, malabsorption syndromes, or antacid abuse) or result from inadequate renal function (eg hyperparathyroidism, Lobaugh, 1995) . In order to counteract hypophosphatemia, the production of 1,25-(OH) 2 D 3 in the kidney is increased, intestinal Ca absorption is enhanced and P is mobilized from bone, while bioactive parathyroid hormone secretion is reduced (Lobaugh, 1995) .
Hyperphosphatemia
Phosphorus plays a key role in mineral metabolism. Dietary phosphorus excess leads to reduced intestinal calcium absorption and 1,25-(OH) 2 D 3 production (Tanaka & Deluca, 1973; Portale et al, 1989; Rodriguez et al, 1991) . Hyperphosphatemia, induced by a high-phosphorus diet in combination with low Ca intake, particularly common in women, is a major stimulus for PTH synthesis and secretion (Reiss et al, 1970; Prince et al, 1993; Nielsen et al, 1996) . Acute hyperphosphatemia is associated with enhanced phosphaturia, followed by a decrease in 1,25-(OH) 2 D 3 synthesis, although only slightly (Portale et al, 1986) , and its target organs' effects being inhibited (Lobaugh, 1995) .
Biochemical markers of bone metabolism
Bone metabolism is characterized by two opposite activities: the formation of new bone by osteoblasts and the degradation of old bone by osteoclasts is expressed by changes of bone metabolic markers ( Figure 1 ) and their relation to biochemical changes of bone (Raisz, 1999; Sto Èrk et al, 2000; Pietschmann & Peterlik, 1999; Yilmaz et al, 1999) . Pyridinoline (Pyd) and deoxypyridinoline (DPD), two markers of collagen breakdown, are amino acids which crosslink adjacent collagen chains. Their advantages as markers of bone remodeling include the fact that they are not metabolized by the body, are excreted unchanged and are not in¯uenced by dietary intake (Tohme Â et al, 1991; Eyre, 1992) . DPD is present mainly in collagen, bone, dentin, and vascular tissue and is therefore a speci®c marker of bone resorption. The crosslinks are only found in natural collagen, whose degradation by collagenase results in release of crosslinks, either free or attached to N-or C-telopeptides (Eriksen et al, 1993) . Their measurement is a sensitive index of the extent of collagen breakdown and, therefore, of bone resorption (Robins, 1995; Mu Èller et al, 1996) . Pyd, DPD and hydroxyproline, the amino-terminal crosslinked telopeptides, are established markers of bone resorption (Figure 1) .
Osteocalcin, an osteoblast-speci®c product found in the skeleton and serum, re¯ects osteoblastic activity and correlates well with histomorphometric parameters of bone formation and is thus a speci®c marker of bone formation rate (Price & Baukol, 1980; Carpenter & Gundberg, 1996) . During vitamin D de®ciency osteocalcin concentration in bone decreases as a direct or indirect function of depletion of the 1,25-(OH) 2 D 3 metabolite (Carpenter & Gundberg, 1996) .
The bone speci®c alkaline phosphatase as well as procollagen also indicates an increase in bone formation (Figure 1 ). Sialoprotein is a major constituent of bone matrix and appears to be involved in both processes of bone formation and resorption (Sto Èrk et al, 2000) .
Kidney function
There are some reports indicating a strong association between high oral phosphorus intake and nephrocalcinosis in children (Reusz et al, 1990) , and in rats (Matsuzaki et al, 1996; Zalups et al, 1983) . High phosphorus supplementation causes a depression of kidney function. One of the typical changes in indicators of kidney function in rats fed a high phosphorus diet is an increase in urinary microalbumin excretion, displaying depression of proximal tubular function (Ritskes-Hoitinga et al, 1989) .
Although the interrelationship between P and Ca homeostasis and their hormonal regulation have long been suggested in short-term experiments regarding cases of extremely inadequate CaXP-ratio, this study was designed to assess the physiological effects of a diet rich in phos- Figure 1 Biochemical markers to assess the rate of bone metabolism.
Effect of high phosphorus intake M Grimm et al phorus and a normal calcium supply. The aim was to determine in particular the in¯uence on endocrine parameters, serum minerals, bone metabolism and renal function in young women over 6 weeks.
Methods

Plan of investigation
Ten women were subjects in the phosphate-loading study, divided into three periods (Figure 2 ).
Period I. The investigation started with a 4 week control period during which the volunteers became familiar with the study and their habitual food intake was determined from the mean of two 7 day dietary records, for a more accurate representation of results. Individual energy supply was quanti®ed using a computer program based on the Bundeslebensmittelschluessel (BLS II.1). During the ®nal 9 days of each period the women were offered a speci®c diet to suit each individual person, corresponding to their 14 day dietary record.
Period II. During a subsequent 6-week period, participants received a dietary supplement of phosphorusenriched orange juice plus four NaH 2 PO 4 tablets. The orange juice contained 975 mg P per bottle (750 ml) while the four tablets contained 620 mg of phosphorus.
Period III. Finally, a 4 week washout period followed without supplements to restore the situation existing before the supplementation period (control period II). All meals were prepared from commercially available foods in the kitchen of the Institute, weighed accurately to the nearest gram and recorded. The subjects consumed only the food provided. Mineral water, milk and orange juice were available to the subjects on demand. This study was approved from an ethical standpoint by the Ethical Committee of the Medical Faculty of the Friedrich Schiller University of Jena, and each volunteer gave written informed consent prior to the study. Additionally, sonographies were examined at the beginning of the study and after the supplementation period, to exclude disorders of kidney function.
Subjects
Observations were made in 10 young women aged 23 ± 29 y. All of them were in good health, with no current or previous history of disease or medications known to alter bone or mineral metabolism and accustomed to normal eating habits as determined from interviews. Initial mean AE s.d. body weight was 60 AE 6 kg with a mean body mass index of 21 AE 2 kgam 2 (Table 1) . Habitual P intakes determined from the 14-day dietary records ranged from 1060 to 1810 mgaday (Table 1 ). All volunteers resided freely and carried out normal activities during the study. In order to coordinate the sample collection, all women were involved in the study at individually suitable times depending on their menstrual cycle. 
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Sample collection and preparation
At the beginning of the study, at the end of each period and in the middle of the supplementation period, blood was taken at 7 am (after an overnight fast) from the vena cubitalis (serum monovettes). Blood samples were centrifuged at 3000 rpm for 20 min and serum was stored at À80 C. Complete 24 h urine collections were made throughout the days when standardized meals were offered and aliquots of each subject were prepared and frozen. After every collection period the aliquots of each woman were mixed and stored at À20 C until analysis.
Analytical methods
Serum-ionized calcium was measured by ion-selective electrode (Beckman LX-20) (Bowers et al, 1986) . Serum phosphorus was determined by a modi®cation of the phosphomolybdat method (Phosphorus Flex TM reagent cartridge no. DF61, DADE, Munich); zinc was determined in the same sample by atomic absorption spectrophotometry (Perkin-Elmer model ELAN 6000, Perkin-Elmer Sciex, USA). Serum was analysed for 1,25-(OH) 2 D 3 using a 125 I radioimmunoassay according to the method of Hollis (1986) . Parathormone was measured by chemiluminescent immunometric assay (IMMUNLITE Intact Pth, DPC, Los Angeles, USA). Calcitonin in serum was determined with a chemiluminescence immunoassay by the method of Weissel et al (1991) . For the determination of intact osteocalcin in human serum a luminescence-immunoassay was used (Hauschka et al, 1989) . The pyridinium crosslinks, Pyd and DPD, were measured in urine by ion-paired reversed-phase HPLC with¯uorescence detection according to Mu Èller et al (1996) . This procedure requires pre-treatment of urine samples by hydrolysis and cellulose chromatography, and measures the total amount of crosslinks, including free and all peptide-bound forms of Pyd and DPD. On the same day, urinary creatinine (Crea) was measured to calculate Pyd or DPD on a comparative basis to Crea (correction of the renal function). Microalbumin, a 1 -microglobulin and b 2 -microglobulin in the urine were determined by kinetic nephelometry using Beckman-IMMAGE TM -immune-chemical systems.
Statistics
Statistical differentiation was performed with the Statistical Package for the Social Sciences (SPSSaPC , version 8.0; SPSS Inc., Chicago, IL, USA). Data were tested for signi®cance of differences between periods with Sidak adjustment for GLM-repeated measurements. For each comparison a value of P`0.05 was considered. Data are presented as the mean AE s.d.
Results
The physical condition of the volunteers remained normal during the study. However, all women reported intestinal disturbance, soft stools or mild diarrhoea throughout the 6 week supplementation period. Energy and protein intake were similar during the three periods (Table 2) . Mean phosphorus intake increased from approximately 1700 mg P per day in the control period I to a mean intake of 3008 mg P per day in the supplementation period ( Table 2 ). The intake of the supplements resulted in a 35% increase in Ca intake in the supplementation period (Table 2) . Table 3 summarises the serum levels of minerals and hormones observed during the three study periods. The mean serum phosphate and calcium concentrations were similar during the three periods (P b 0.05; Table 3 ). No changes in serum levels of zinc occurred (Table 3) .
During the treatment, the serum PTH concentration rose by 32% and returned to baseline in the control period II (Table 3 ). There were no signi®cant differences between Serum osteocalcin changed signi®cantly during the study (P`0.05), between the control period I and the control period II. The supplementation period was not signi®cantly different from the control periods (Table 3) .
The majority of the serum samples analysed for calcitonin were below the sensitivity of the assay, and hence no direct estimate could be made of the effect of diet on serum calcitonin levels in these subjects.
The excretion of pyridinoline showed a tendency to increase (86%) during high phosphorus intake (Figure 3) . The excretion of deoxypyridinoline was also elevated by Figure 3 Changes in urinary pyridinoline (Pyd) and deoxypyridinoline (DPD) in response to high phosphorus intake in the supplementation period. There was no signi®cant change in either measurement. The thick line represents the mean. Effect of high phosphorus intake M Grimm et al 80% during high phosphorus intake. Because of the high standard deviation in the supplementation period the differences were not signi®cant. As a consequence, the mean PydaDPD ratio did not change within the study. As shown in Table 4 , urinary microalbumin excretion was decreased after introduction of the high-phosphorus diet, b-2-microglobulin remained unchanged and a-1-microglobulin was below the sensitivity of the assay. There were no signi®cant changes in either measured indicator of proximal tubular function.
Discussion
Using an intervention study design, we have investigated the effects of a high phosphorus intake on calcium, phosphorus and zinc absorption and bone turnover as well as kidney function in young females. The introduction of a diet rich in phosphorus was associated with intestinal distress, soft stools or mild diarrhoea in young women. This physiological response to phosphorus supplementation in the present study was in agreement with that observed by Bell et al (1977) . In their investigation eight human subjects ®rst received a control diet containing 1 g P per day for 4 weeks; this was followed by 4 further weeks with a high-phosphorus diet providing approximately 2.1 g of phosphorus in the form of sodium polyphosphates. The symptoms resulting during high phosphorus intake were probably the consequence of an osmotic effect of the added polyphosphates in the intestinal lumen. Phosphates are absorbed in a range between 20% and 80%, depending on the chemical form (Feldheim, 1981) . Therefore, various sodium phosphates are often used medicinally as mild saline cathartics.
Although more phosphorus and calcium was supplied in the supplementation period, serum levels of Ca, P and Zn did not vary between the periods (Table 3) . Under physiological conditions, calcium serum concentrations subject to strong homeostatic control and changes, such as hypo-or hypercalcemia, can only be measured in short-term experiments (Table 5) . Herbert et al (1966) reported that phosphate infusion, diets high in phosphorus and oral supplementation of phosphates decrease the serum levels of calcium. This is probably due to biochemical interactions between calcium and phosphate (Reiss et al, 1970) . Reiss et al observed hypocalcemia in response to a high phosphorus intake (1 g P as sodium phosphate). Consequently, PTH rose by 60 to 125%. These results have been con®rmed by Lobaugh (1995) and Silverberg et al (1986) . Parathyroid hormone is generally known as the most important regulator of 1,25-(OH) 2 D 3 . Previous studies have demonstrated that, in order to counteract hyperphosphataemia, bioactive parathyroid hormone secretion is raised (Table 5 ; Reiss et al, 1970; Silverberg et al, 1986) . However, hyperphosphatemia, induced by a high phosphorus intake, is associated with a decrease of 1,25-(OH) 2 D 3 concentration in the serum (Lobaugh, 1995; Portale et al, 1987) . Contrary to this, Silverberg et al (1986) noticed no changes in 1,25-(OH) 2 D 3 concentrations (Table 5) . Calvo et al (1990) studied 15 young women (aged 18 ± 25 y) in their hormonal response to a high P, low Ca intake and control diets. After consuming a basal diet (900 mg P per day), subjects were switched to a diet containing 1700 mg Paday for 4 weeks. During the high phosphorus diet serum PTH increased signi®cantly between 26% and 36% while levels of 1,25-(OH) 2 D 3 did not change (Table 5) .
Calvo et al (1991) declared a circadian rhythm for PTH which is similar to that of serum phosphorus. In our investigation blood was drawn after an overnight fast, therefore we found no changes in the morning serum concentration of phosphorus and, thus, no hyperphosphatemia was measured, and only slight insigni®cant changes in the morning fasting concentrations of PTH (32% increase during the supplementation period). Despite this mild elevation of serum PTH, serum levels of the active metabolite of vitamin D showed no alteration in either period. This ®nding of no changes in serum 1,25-(OH) 2 D 3 is consistent with the results discussed above, suggesting that long-term phosphorus supplementation impairs usual homeostatic mechanisms to compensate for low calcium intake (Table 5) . 
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Measurements of the calcium-regulating hormones PTH and of 1,25-(OH) 2 D 3 are helpful but they do not necessarily re¯ect bone resorption. Therefore we measured serum osteocalcin as a bone formation marker and urinary pyridinium crosslinks as markers of bone resorption. Less is known about their behavior under phosphorus supplementation. In vitro studies have shown that phosphate may directly inhibit bone resorption. Price and Baukol (1980) observed that 1,25-(OH) 2 D 3 directly stimulate osteoblasts to produce osteocalcin. However, the results discussed above have demonstrated that increased phosphorus intakes do not regularly lead to changes in serum 1,25-(OH) 2 D 3 levels. Furthermore, PTH directly impairs osteocalcin synthesis in osteoblasts in vitro (Lian et al, 1987) and, after infusion of PTH in humans, serum osteocalcin, decreased (Riggs et al, 1984) . In our study serum levels of 1,25-(OH) 2 D 3 did not change but serum PTH concentration increased slightly during phosphorus supplementation. On the other hand, we observed a decrease in serum osteocalcin levels which is due to a reduced activity of osteoblasts (Table 3) . Moreover Woitge et al (1998) found a signi®cant seasonal variation in serum osteocalcin. Peak values were seen in February, and the nadir occurred in July (Thomsen et al, 1989) . Because of menstrual cycles the present study lasted from February until June. Therefore the statistically signi®cant higher concentration of osteocalcin in winter than in summer could be due to seasonal in¯uence.
However, the urinary pyridinium crosslinks, pyridinoline and deoxypyridinoline, re¯ect the activity of osteoclasts. Pyd and DPD provide structural integrity and rigidity to collagen ®brils in bone. During bone degradation and resorption, the crosslinks are released into the circulation and eventually excreted in urine (Mu Èller et al, 1996) . Hoshino et al (1998) reported an increased rate of bone resorption with advancing rachitis in rats, induced by phosphate de®ciency, and concluded an impaired mineralization followed by an increased synthesis of pyridinoline in bone collagen. Furthermore, there was a signi®cant increase in urinary pyridinoline and deoxypyridinoline in rats. In humans, the bone resorption marker urinary deoxypyridinoline was unaffected by the ingestion of phosphorus (Ka Èrkka Èinen & Lambert-Allardt, 1996) or tended to increase (Bizik et al, 1996) . This con®rmation of our results, which show that deoxypyridinoline as well as pyridinoline tended to increase during phosphorus supplementation. This could be due to increased osteoclastic bone resorption.
Very few investigations of the interaction between dietary phosphorus and kidney function have been conducted. Karlinsky et al (1980) measured the in¯uence of altered dietary phosphorus on the subsequent development of nephrotoxic serum nephritis in rats. Control animals fed a phosphorus-adequate diet developed a glomerulonephritis characterized by progressive renal failure, elevated concentrations of creatinine in serum, proteinuria and early death (Karlinsky et al, 1980) . Contrarily, animals consuming a low-phosphorus diet had signi®cantly lower serum creatinine concentrations, maintained a normal level of renal function, and showed less accelerated mortality. Restriction of phosphorous in the diet resulted in reduced renal damage and less histological injury in the phosphorus-de®cient mice (Karlinsky et al, 1980) . One of the typical indicators of changes in kidney function is urinary microalbumin excretion. High phosphorus diets induce nephrocalcinosis and depression of kidney function in rats (Matsuzaki et al, 1997 (Matsuzaki et al, , 1998 Karlinsky et al, 1980) . The excretion in urinary microalbumin increased, caused by a defect in the permeability of the renal glomerular basement membrane. This may be due to obstruction of the proximal tubular albumin reabsorption. Another typical effect of phosphorus supplementation in rats is an increase in urinary b-2-microglobulin excretion, which indicates impaired proximal tubular function (Matsuzaki et al, 1997) . In contrast, in our study with young women, urinary microalbumin excretion tended to decrease and the excretion of b-2-microglobulin remained unchanged.
In conclusion, the introduction of phosphorus supplementation was associated with intestinal distress, soft stools or mild diarrhoea. The high-phosphorus diet induced no signi®cant changes in serum levels of Ca, PO 4 or Zn. There was a tendency to increased serum concentrations of parathyroid hormone while 1,25-dihydroxychole-calciferol remained unchanged during the supplementation period and osteocalcin decreased. Urinary pyridinium crosslinks, pyridinoline and deoxypyridinoline, as speci®c markers of bone resorption, showed only slight increases during the high phosphorus intake. As indicators of proximal tubular function, urinary microalbumin excretion was lower in the high-phosphorus diet (P b 0.05), b-2-microglobulin remained unchanged and a-1-microglobulin levels were below the sensitivity of the assay.
When taking serum and urine samples we took into account the menstrual cycles of the women included in this study and each woman followed an individual study design. Moreover, the time-spans between the three study periods were long (4 ± 6 weeks) and the study was performed with two control periods for which reason we do not believe that the¯uctuations in hormones during the menstrual period have any in¯uence on the results presented.
From our study it can be concluded that, in women with normal Ca supply and P excess, there was no acute increase in resorption despite the slight rise in PTH concentration and the signi®cant decrease of osteocalcin levels in the serum which could be due to the inhibitory effect of phosphate and PTH on bone resorption. We conclude that in spite of high P supplementation no signi®cant changes of bone-related hormones, pyridinium crosslinks as markers of bone resorption and parameters of renal function were measured.
